Etta Pisano to Neoadjuvant Therapy
This is a "connection" page, showing publications Etta Pisano has written about Neoadjuvant Therapy.
Connection Strength
0.257
-
MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial. AJR Am J Roentgenol. 2018 Jun; 210(6):1376-1385.
Score: 0.145
-
The role of magnetic resonance imaging in diagnosis and management of breast cancer. Technol Cancer Res Treat. 2004 Dec; 3(6):527-41.
Score: 0.057
-
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL. Radiology. 2016 Apr; 279(1):44-55.
Score: 0.031
-
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology. 2012 Jun; 263(3):663-72.
Score: 0.024